07
Feb
Tech Breakthrough or Time Bomb - Lachman Blog

Tech Breakthrough or Time Bomb? AI Learns to Copy Itself

Artificial intelligence is advancing at an unprecedented speed, with breakthroughs happening almost daily. One of the most fascinating—and potentially unsettling—developments is the idea that AI systems could replicate themselves. Picture an AI model so advanced that it can create a duplicate of its own functionality. What once sounded like pure science fiction is now inching […]

Read More
04
Nov
Laptop Cartoon - Thinking

Cybersecurity and AI: Navigating the Digital Frontier

In an era of rapid technological breakthroughs, the incorporation of artificial intelligence (AI) into numerous industries is transforming the way in which we all work. AI has been shown to be a valuable tool for automating mundane processes and analyzing large datasets. However, as we embrace its potential, we must also address the cybersecurity threats […]

Read More
29
Apr

Jam the Scammers – A Group of White Hats Step Up – and You Can’t Even See Them at Work

With a sense of honor and the common good, last month some scammers “promised to refrain” from attacking healthcare operations during the COVID-19 pandemic.  Unfortunately, some people believed them! I get it.  This virus impacts every one of us.  We all would like to believe that, in this current environment, people will step up and […]

Read More
21
Apr

Sci-Fi to Reality!

Science fiction has always been the white board for technological innovation.  Think of all the books and/or movies you have digested.  How many times have you said, “well, that will never happen?” And looking back, how many futuristic concepts have eventually become reality?  More than you may realize. Let me give you a few fun […]

Read More
24
Mar

In Times of Crisis, Cyber Threats Increase – Be Wary

As the coronavirus spreads around the globe, unfortunately so do cyber-criminal attacks.  Cyber criminals see this as a golden opportunity to capitalize.  Hackers leverage the panic, confusion, and misinformation to transmit malware, breach computer networks, set up malicious websites, and launch social engineering attacks. Early on in the coronavirus pandemic, the Cybersecurity and Infrastructure Security […]

Read More
18
Feb
Budget friendly health brands

When It Rains, It Pours; Recent Rx-to-OTC Switches

February 14, 2020 could be called a red letter day in the world of Rx-to-OTC switch.  After a long period of drought, FDA announced that they have approved the Rx-to-OTC switch of three prescription drugs. Please see the announcement here.  The three drugs are: Voltaren Arthritis Pain (diclofenac sodium topical gel, 1%) for the temporary […]

Read More
13
Feb
The Queens Guard

Looking at the Sentinel

FDA has announced the 12th Annual FDA Sentinel Public Workshop on April 20-21, 2020. (Please go here for the details.)  The Sentinel System is the largest multi site patient safety database in the world, and includes the Active Post-marketing Risk Identification and Analysis (ARIA) system mandated by Congress in the US Food and Drug Administration […]

Read More
06
Feb
Abstract Molecular Structure

Revisiting the “Novelty” of Novel Excipients

February 3, 2020 was the last day to comment on the Food and Drug Administration’s (FDA) notice in the Federal Register on the Novel Excipient Review Program Proposal; Request for Information and Comments (here), which we reported on in a previous blog post (here).  In this notice, the FDA had proposed a pilot program related […]

Read More
05
Feb
Researcher adding liquid from test tube with fire symbol, warning sign, danger

The “Unwelcome Guest” Spares Metformin

Recently, FDA has posted (here) that Metformin, from several sources, tested by FDA showed that the levels of N-nitroso-dimethylamine (NDMA) in the drug are below the levels of detection (here).  Great news!  NDMA belongs to the nitrosamine family, and is one of the well-known animal carcinogens and a suspected human carcinogen.  The nitrosamines, including NDMA, […]

Read More
1 2 3